Table 1 Correlation between MK expression and clinicopathologic factors in pancreatic head carcinoma

From: Clinical significance of midkine expression in pancreatic head carcinoma

  

MK expression

 
 

Total n =75

Positive n =40 (53.3%)

Negative n =35 (46.7%)

P -values

Age (years)

 Mean±s.d.

 

67.4±8.9

64.9±9.9

0.2648

Gender

 Male

50 (66.7)

23 (57.5)

27 (77.1)

0.0718

 Female

25 (33.3)

17 (42.5)

8 (22.9)

 

Histology

 Well

29 (38.7)

14 (35.0)

15 (42.9)

0.2318

 Moderately

43 (57.3)

23 (57.5)

20 (57.1)

 

 Poor

3 (4.0)

3 (7.5)

0 (0.0)

 

pT

 pT1

3 (4.0)

1 (2.5)

2 (5.7)

0.3699

 pT2

5 (6.7)

1 (2.5)

4 (11.4)

 

 pT3

59 (78.7)

33 (82.5)

26 (74.3)

 

 pT4

8 (10.7)

5 (12.5)

3 (8.6)

 

pN

    

 Negative

28 (37.3)

14 (35.0)

14 (40.0)

0.6552

 Positive

47 (62.7)

26 (65.0)

21 (60.0)

 

Liver metastasis

 Negative

47 (62.7)

20 (50.0)

27 (77.1)

0.0153

 Positive

28 (37.3)

20 (50.0)

8 (22.9)

 

pStage

 I

6 (8.0)

1 (2.5)

5 (14.3)

0.3651

 IIA

21 (28.0)

13 (32.5)

8 (22.9)

 

 IIB

38 (50.7)

20 (50.0)

18 (51.4)

 

 III

6 (8.0)

4 (10.0)

2 (5.7)

 

 IV

4 (5.3)

2 (5.0)

2 (5.7)

 

Lymphatic invasion

 Negative

9 (12.0)

4 (10.0)

5 (14.3)

0.5688

 Positive

66 (88.0)

36 (90.0)

30 (85.7)

 

Venous invasion

 Negative

19 (25.3)

5 (12.5)

14 (40.0)

0.0063

 Positive

56 (74.7)

35 (87.5)

21 (60.0)

 

Microvessel density

 Low grade

33 (44.0)

11 (27.5)

22 (62.9)

0.0021

 High grade

42 (56.0)

29 (72.5)

13 (37.1)

 
  1. MK=midkine; s.d.=standard deviation.